Title: Metabolite identification via LC-SPE-NMR-MS of the in vitro biooxidation products of a lead mGlu5 allosteric antagonist and impact on the improvement of metabolic stability in the series.
Journal: ChemMedChem 20080101
3575-09-5
5469-94-3 | p-malonotoluidide | AA00DID2 | MFCD00419232
515141-51-2 | 6-(4-Chlorophenyl)-3-(3-methoxy-4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)thieno[3,2-d]pyrimidin-4(3H)-one | AA00DIM2 | MFCD09970889
439095-25-7 | Benzyl n-[2-methyl-1-(phenylsulfonyl)propyl]carbamate | AA00DIWO | MFCD03012203
51632-12-3 | 2-(4-Bromophenyl)-3-methylbutanenitrile | AA00DJ7Z | MFCD11592218
51036-12-5 | Piperidine-3-sulfonic acid | AA00DJJ9 | MFCD13179328
54752-50-0 | 7-(Trifluoromethyl)-1-tetralone | AA00DJQJ | MFCD08234368
468718-65-2 | 4-bromo-N-methylpyridin-2-amine | AA00DK1Y | MFCD09834845
5435-92-7 | 2-Chloro-4-phenylbenzonitrile | AA00DKCV | MFCD14701624
532965-74-5 | 4-Ethoxy-2-fluorobenzaldehyde | AA00DKHP | MFCD06247347
56181-38-5 | 5-Bromo-N-methylpyrimidin-4-amine | AA00DKNQ | MFCD03861147